Kang YS, Jeong HS, Kim TS, Yun HS, Kim DJ, Yun JH, Lee SG, Ji HG, Ham GH, Lee JH, Shin DB
- KMID: 1531935
-
J Korean Cancer Assoc.
-
1997 Feb;29(1):160-170.
PURPOSE: Important advances in the treatment of acute myelogenous leukemia have been made with the introduction of cytosine arabinoside (ara-C) and anthracyclines (daunorubicin) over the past 20 years. Currently, 60...